Introduction
Articular cartilage is an avascular, aneural connective tissue which plays a key role in synovial joint function by providing bony elements with a smooth, load-bearing surface. Its organisation into characteristic zones is implicit not only to its growth but also its functioning, and is commonly disrupted through trauma or disease in adulthood. To date, there is little evidence to suggest that the zonal organisation of articular cartilage can be repaired following insult. An understanding of the control mechanisms involved in regulating the development and growth of the characteristic zones of the tissue would clearly, therefore, be pertinent to a repair strategy. In previous studies we have reported that articular cartilage grows by apposition from the articular surface; the tissue thus increases in size by a process of replacement rather than remodelling (1,2). This finding has led us to the hypothesis that a chondroprogenitor, or articular cartilage 'stem' cell resides within the articular surface, and this undergoes a progressive programme of maturation until terminal differentiation, thus forming the characteristic zones of the mature tissue. The progression of cells through each step in the chondrocyte differentiation pathway would obviously need to be carefully controlled to ensure coordinated growth of the tissue as a whole. Since the Delta-Notch/ Serrate-Notch signalling systems are known to regulate cell fate decisions during development (3) we have examined the involvement of these molecules in regulating cell fate decisions during the development and growth of articular cartilage. Methods BalbC mice were humanely killed and their hindlimbs removed at regular stages during embryonic and post-natal development (embryonic day 16 -3 months post-natal). All specimens were fixed in cold 95% alcohol, decalcified in 10% EDTA (Sigma) until radiographically clear and frozen onto cryostat stubs using Cryo-M-Bed tissue mountant (Bright Instrument Co.). Limbs were cryosectioned at 10µm in the sagittal plane using a Bright Cryostat and sections through the knee joint collected onto APES-coated slides (Sigma). Sections were ringed with a water-repellant pen (Vector Laboratories) and labelled by standard immunofluorescence procedures with a panel of antibodies to Notch receptors and their ligands (all antibodies obtained from Santa Cruz Biotechnologies). Polyclonal antibodies to Notch-1 (no. sc6104), Notch-2 (no. sc5545), Notch-3 (no. sc7424), Notch-4 (no. sc8645), Delta-1 (no. sc9102), Serrate-1 (no. sc8303) and Serrate-2 (no. sc8158) were all used at a concentration of 10µg/ml. Bound antibody was detected by FITCconjugated secondary antibodies (Sigma; 1:100 dilution). Sections were counterstained with propidium iodide (Molecular Probes;1µg/ml) and mounted in Vectashield (Vector Laboratories, Inc.) before examination with a Molecular Dynamics Sarastro 2000 confocal microscope equipped with Silicon Graphics Iris/Indigo workstations. Results Notch receptors: The four Notch homologs had distinct distributions during foetal and post-natal development. Pre-natally, Notch-1 was detectable in the joint interzone of the developing knee joint and in the perichondrium, occurring as plaques of cell surface-associated immunolabel. After knee joint cavitation had begun at E17, Notch-1 became localised to a specific population of cells at the articular surface (2-3 cells thick). Post-natally, Notch-1 immunolabel was reduced at the articular surface but became increasingly prominent on hypertrophic cells prior to formation of the secondary centre of ossification in the cartilaginous epiphyses. After ossification had occurred, Notch-1 label was detectable on many cells throughout the articular cartilage depth. Notch-2 and Notch-4 had similar distributions during articular cartilage development. Prenatally, both occurred in the joint interzone and throughout the cartilage anlagen of the limb, occurring as plaques of cell surface-associated label. Post-natally, the intensity and extent of labelling for borth ligands became increased on hypertrophic cells, similar to that described for Notch-1. Notch-2 and Notch-4 were also prominent in other connective tissues of the developing knee joint, particularly in tendon where bright punctate labelling occurred between adjacent tenocytes. Notch-3 did not appear to be associated with cartilage development prenatally, however during post-natal development it also became prominent on the surface of hypertrophic chondrocytes, similar to that described for the other Notch isoforms. Notch ligands: Delta-1, Serrate-1 and Serrate-2 were widely distributed on cells throughout foetal and post-natal development. During early foetal stages, all three ligands were detectable on cells of the joint interzone and on chondrocytes throughout the primitive cartilage models of the developing knee joint, occurring as plaques of cell surface-associated immunolabel. Prior to formation of the secondary centre of ossification in the cartilaginous epiphyses, labelling for Delta-1 became particularly prominent on prehypertrophic chondrocytes. The labelling pattern for Serrate-1 and Serrate-2 was more widespread at this stage -these ligands were also prominent on hypertrophic cells, having similar distributions to those described for the Notch receptors. After formation of the secondary centre of ossification, immunolabel for each of the Notch ligands was detectable on mainy cells throughout the articular cartilage depth. Discussion The Delta/Notch and Serrate/Notch ligand/receptor pairs are highly conserved signalling systems involved in regulating cell fate decisions during the development of a wide range of tissues. The transmembrane ligands Delta and Serrate activate their receptor Notch on adjacent cells resulting in signalling that can either induce or inhibit cell differentiation (3). Although the precise molecular interactions remain to be elucidated, the results of the present study indicate that both Delta-Notch and Serrate-Notch signalling pathways are involved in regulating aspects of chondrocyte differentiation during articular cartilage development. In addition, as far as we are aware, this is the first report describing the presence of Notch-1 in superficial zone cells during early articular cartilage development. This observation is significant, as it suggests that this receptor may be involved in regulating the differentiation state of surface zone cells, which we consider to be a chondroprogenitor or stem cell population. The later appearance of Delta-1 on prehypertrophic cells after birth supports previous findings that this ligand negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation, ie it inhibits chondrocyte maturation (4). Finally, the occurrence of all Notch 1-4 and their ligands on hypertrophic chondrocytes prior to the onset of ossification, suggests that both Delta-Notch and Serrate-Notch signalling may be involved in regulating the terminal differentiation of chondrocytes during articular cartilage growth.
